Differential G protein activation by the long and short isoforms of the dopamine D2 receptor

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Differential G protein activation by the long and short isoforms of the dopamine D2 receptor. / Reiner-Link, David; Madsen, Jakob Sture; Gloriam, David E.; Bräuner-Osborne, Hans; Hauser, Alexander S.

I: British Journal of Pharmacology, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Reiner-Link, D, Madsen, JS, Gloriam, DE, Bräuner-Osborne, H & Hauser, AS 2024, 'Differential G protein activation by the long and short isoforms of the dopamine D2 receptor', British Journal of Pharmacology. https://doi.org/10.1111/bph.16388

APA

Reiner-Link, D., Madsen, J. S., Gloriam, D. E., Bräuner-Osborne, H., & Hauser, A. S. (Accepteret/In press). Differential G protein activation by the long and short isoforms of the dopamine D2 receptor. British Journal of Pharmacology. https://doi.org/10.1111/bph.16388

Vancouver

Reiner-Link D, Madsen JS, Gloriam DE, Bräuner-Osborne H, Hauser AS. Differential G protein activation by the long and short isoforms of the dopamine D2 receptor. British Journal of Pharmacology. 2024. https://doi.org/10.1111/bph.16388

Author

Reiner-Link, David ; Madsen, Jakob Sture ; Gloriam, David E. ; Bräuner-Osborne, Hans ; Hauser, Alexander S. / Differential G protein activation by the long and short isoforms of the dopamine D2 receptor. I: British Journal of Pharmacology. 2024.

Bibtex

@article{f7d63530fbca4e9198c168ae93828633,
title = "Differential G protein activation by the long and short isoforms of the dopamine D2 receptor",
abstract = "Background and Purpose: The dopamine D2 receptor is expressed as a short (D2S) and a long (D2L) isoform with 29 additional amino acids in the third intracellular loop. The D2S isoform shows higher presynaptic expression than the D2L isoform, and decreased D2S expression has recently been linked to an increased risk for schizophrenia. Here, we present the first investigation, at receptor isoform level, of kinetic differences in the G protein activation profiles of the D2S, compared with the D2L isoform. Experimental Approach: We employed a NanoBRET-based approach to G protein dissociation to interrogate the time-resolved coupling profile of 3×HA-tagged D2L and D2S to Gαi/o/z proteins in vitro. Key Results: Using dopamine as a D2 receptor agonist, we observed a more pronounced activation of Gαo and Gαz than Gαi proteins by D2L compared with D2S. This differentiation was not observed for D2S, which activated Gαo and Gαz with lower efficacy than D2L. These signalling differences were preserved on second messenger level and were not due to differences in receptor expression. Expanding to a set of seven full and partial D2 receptor agonists showed these effects were not restricted to dopamine but rather a mutual, receptor-associated property. Contrasting this trend, we found that D2S activated G proteins faster than D2L upon full receptor activation. Conclusion and Implications: The findings highlight that both D2L and D2S are mechanistically able to activate all non-visual Gαi/o proteins. Thereby, they add to previous reports about isoform-specificity to certain Gαi/o proteins observed in specific cell types.",
keywords = "D2L, D2S, dopamine D2 receptor, G protein activation, splice variants",
author = "David Reiner-Link and Madsen, {Jakob Sture} and Gloriam, {David E.} and Hans Br{\"a}uner-Osborne and Hauser, {Alexander S.}",
note = "Publisher Copyright: {\textcopyright} 2024 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.",
year = "2024",
doi = "10.1111/bph.16388",
language = "English",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley",

}

RIS

TY - JOUR

T1 - Differential G protein activation by the long and short isoforms of the dopamine D2 receptor

AU - Reiner-Link, David

AU - Madsen, Jakob Sture

AU - Gloriam, David E.

AU - Bräuner-Osborne, Hans

AU - Hauser, Alexander S.

N1 - Publisher Copyright: © 2024 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

PY - 2024

Y1 - 2024

N2 - Background and Purpose: The dopamine D2 receptor is expressed as a short (D2S) and a long (D2L) isoform with 29 additional amino acids in the third intracellular loop. The D2S isoform shows higher presynaptic expression than the D2L isoform, and decreased D2S expression has recently been linked to an increased risk for schizophrenia. Here, we present the first investigation, at receptor isoform level, of kinetic differences in the G protein activation profiles of the D2S, compared with the D2L isoform. Experimental Approach: We employed a NanoBRET-based approach to G protein dissociation to interrogate the time-resolved coupling profile of 3×HA-tagged D2L and D2S to Gαi/o/z proteins in vitro. Key Results: Using dopamine as a D2 receptor agonist, we observed a more pronounced activation of Gαo and Gαz than Gαi proteins by D2L compared with D2S. This differentiation was not observed for D2S, which activated Gαo and Gαz with lower efficacy than D2L. These signalling differences were preserved on second messenger level and were not due to differences in receptor expression. Expanding to a set of seven full and partial D2 receptor agonists showed these effects were not restricted to dopamine but rather a mutual, receptor-associated property. Contrasting this trend, we found that D2S activated G proteins faster than D2L upon full receptor activation. Conclusion and Implications: The findings highlight that both D2L and D2S are mechanistically able to activate all non-visual Gαi/o proteins. Thereby, they add to previous reports about isoform-specificity to certain Gαi/o proteins observed in specific cell types.

AB - Background and Purpose: The dopamine D2 receptor is expressed as a short (D2S) and a long (D2L) isoform with 29 additional amino acids in the third intracellular loop. The D2S isoform shows higher presynaptic expression than the D2L isoform, and decreased D2S expression has recently been linked to an increased risk for schizophrenia. Here, we present the first investigation, at receptor isoform level, of kinetic differences in the G protein activation profiles of the D2S, compared with the D2L isoform. Experimental Approach: We employed a NanoBRET-based approach to G protein dissociation to interrogate the time-resolved coupling profile of 3×HA-tagged D2L and D2S to Gαi/o/z proteins in vitro. Key Results: Using dopamine as a D2 receptor agonist, we observed a more pronounced activation of Gαo and Gαz than Gαi proteins by D2L compared with D2S. This differentiation was not observed for D2S, which activated Gαo and Gαz with lower efficacy than D2L. These signalling differences were preserved on second messenger level and were not due to differences in receptor expression. Expanding to a set of seven full and partial D2 receptor agonists showed these effects were not restricted to dopamine but rather a mutual, receptor-associated property. Contrasting this trend, we found that D2S activated G proteins faster than D2L upon full receptor activation. Conclusion and Implications: The findings highlight that both D2L and D2S are mechanistically able to activate all non-visual Gαi/o proteins. Thereby, they add to previous reports about isoform-specificity to certain Gαi/o proteins observed in specific cell types.

KW - D2L

KW - D2S

KW - dopamine D2 receptor

KW - G protein activation

KW - splice variants

U2 - 10.1111/bph.16388

DO - 10.1111/bph.16388

M3 - Journal article

C2 - 38725357

AN - SCOPUS:85192553660

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

ER -

ID: 392449877